compound 8a [PMID: 35500474]   Click here for help

GtoPdb Ligand ID: 13121

Compound class: Synthetic organic
Comment: This is one of the most potent dual PARP10/PARP15 inhibitors reported in this 2022 study [1]. Dual PARP10/PARP15 inhibition is being examined for clinical anti-tumour efficacy.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 67.43
Molecular weight 274.32
XLogP 3.17
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1CCC(CC1)COC2=CC=C3C(=C2)C(=O)NNC3=O
Isomeric SMILES O=C1NNC(=O)C2=C1C=CC(OCC3CCCCC3)=C2
InChI InChI=1S/C15H18N2O3/c18-14-12-7-6-11(8-13(12)15(19)17-16-14)20-9-10-4-2-1-3-5-10/h6-8,10H,1-5,9H2,(H,16,18)(H,17,19)
InChI Key PCAWJIMDNGAMRA-UHFFFAOYSA-N
References
1. Nizi MG, Maksimainen MM, Murthy S, Massari S, Alaviuhkola J, Lippok BE, Sowa ST, Galera-Prat A, Prunskaite-Hyyryläinen R, Lüscher B et al.. (2022)
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15.
Eur J Med Chem, 237: 114362. [PMID:35500474]